Position in GILD
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$332,996,991
-$70,133,800 QoQ
Shares Held
2,635,721
-8.9% QoQ
Ownership
0.213%
of shares outstanding
% of Portfolio
0.61%
of 13F equity value
Holder Rank
#61
of 2,275 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 64%
Shared 0%
None 36%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LSV ASSET MANAGEMENT holds $2,451,058,699 across 9 Drug Manufacturers - General names. GILD ranks #4 (13.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
5,299,408 | $680,973,928 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
9,852,232 | $567,685,607 | |
| 3 | PFE |
Pfizer Inc
|
18,940,504 | $456,087,336 | |
| 4 | GILD |
Gilead Sciences, Inc.
This page
|
2,635,721 | $332,996,991 | |
| 5 | AMGN |
Amgen Inc
|
603,549 | $218,557,163 | |
| 6 | BIIB |
Biogen Inc.
|
444,049 | $95,941,226 | |
| 7 | OGN |
Organon & Co.
|
3,737,036 | $50,599,467 | |
| 8 | JNJ |
Johnson & Johnson
|
184,693 | $46,906,481 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $332,996,991 | 2,635,721 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $403,130,791 | 2,892,522 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $508,914,407 | 4,146,280 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $477,254,823 | 4,299,593 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $500,874,072 | 4,517,670 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $551,262,469 | 4,919,790 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $464,482,360 | 5,028,498 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $443,334,853 | 5,287,868 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $378,033,484 | 5,509,889 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $415,821,864 | 5,676,749 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $480,227,198 | 5,927,999 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $459,997,382 | 6,138,209 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $484,960,585 | 6,292,469 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $538,037,965 | 6,484,729 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $563,663,456 | 6,565,678 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $412,245,214 | 6,682,529 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $404,653,195 | 6,546,727 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $329,839,836 | 5,548,189 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $370,536,091 | 5,103,100 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $302,708,316 | 4,333,691 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $286,648,893 | 4,162,778 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $270,699,523 | 4,188,450 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $255,682,749 | 4,388,650 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $289,546,058 | 4,582,150 | Shares | Sole | 2020-10-23 | |
| 2020-06-30 | $347,166,205 | 4,512,168 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $336,062,946 | 4,495,224 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||